About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ctnna1tm1Efu
targeted mutation 1, Elaine Fuchs
MGI:2677796
Summary 9 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ctnna1tm1Efu/Ctnna1tm1Efu involves: 129X1/SvJ MGI:3830548
cn2
Ctnna1em1Xjz/Ctnna1tm1Efu
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6J * C57BL/6NCrl * CBA MGI:7467130
cn3
Ctnna1tm1Efu/Ctnna1tm1Efu
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6NCrl * CBA MGI:7467113
cn4
Ctnna1tm1Efu/Ctnna1tm1Efu
Twist2tm1(cre)Dor/Twist2+
involves: 129X1/SvJ MGI:5299326
cn5
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(KRT14-cre)1Efu/?
involves: 129X1/SvJ MGI:3720633
cn6
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(Nes-cre)1Kln/?
involves: 129X1/SvJ * C57BL/6 * SJL MGI:3720627
cn7
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(Wap-cre)11738Mam/?
involves: 129X1/SvJ * C57BL/6 * SJL MGI:3720651
cn8
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(MMTV-cre)4Mam/?
involves: 129X1/SvJ * FVB MGI:3720649
cn9
Ctnna1tm1Efu/Ctnna1tm1Efu
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129X1/SvJ * FVB/N MGI:5504499


Genotype
MGI:3830548
hm1
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Genetic
Background
involves: 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
integument
• mice exhibit increased apoptosis in the epidermis compared to wild-type mice




Genotype
MGI:7467130
cn2
Allelic
Composition
Ctnna1em1Xjz/Ctnna1tm1Efu
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
Genetic
Background
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6J * C57BL/6NCrl * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1em1Xjz mutation (0 available); any Ctnna1 mutation (133 available)
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze mutation (5 available); any Gt(ROSA)26Sor mutation (944 available)
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• slower growth of horizontal blood vessels in retina at age P7 after tamoxifen administration from age P1-P4
• increased blood vessel leakage in retina at age P7 after tamoxifen administration from age P1-P4

vision/eye
• slower growth of horizontal blood vessels in retina at age P7 after tamoxifen administration from age P1-P4
• increased blood vessel leakage at age P7 after tamoxifen administration from age P1-P4

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
exudative vitreoretinopathy DOID:0050535 OMIM:PS133780
J:328283




Genotype
MGI:7467113
cn3
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
Genetic
Background
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6NCrl * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze mutation (5 available); any Gt(ROSA)26Sor mutation (944 available)
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• slower growth of horizontal blood vessels in retina at age P3 during tamoxifen administration from age P1-P4
• slower growth of horizontal blood vessels in retina at age P9 after tamoxifen administration from age P1-P4
• delayed growth of vertical blood vessels in superficial retina vascular plexus at age P9 after tamoxifen administration from age P1-P
• lack of vertical secondary and tertiary vessels in retina at age P9 after tamoxifen administration from age P1-P4
• defects of vascular growth into deeper layers of retina at age P9 after tamoxifen administration from age P1-P4
• defects in periphery of superficial retina vascular plexus at age P13 after tamoxifen administration from age P6
• fewer vessels in retina OPL and minimal vessels in retina IPL at age P13 after tamoxifen administration from age P6
• enlarged superficial vessels in retina at age P9 after tamoxifen administration from age P1-P4
• enlarged blood vessels in brain at age P9 after tamoxifen administration from age P1-P4
• in eyes after tamoxifen administration from age P1-P4
• extensive blood leakage in brain at age P9 after tamoxifen administration from age P1-P4

vision/eye
• slower growth of horizontal blood vessels at age P3 during tamoxifen administration from age P1-P4
• slower growth of horizontal blood vessels and enlarged superficial vessels at age P9 after tamoxifen administration from age P1-P4
• delayed growth of vertical blood vessels in superficial retina vascular plexus at age P9 after tamoxifen administration from age P1-P4
• lack of vertical secondary and tertiary vessels at age P9 after tamoxifen administration from age P1-P4
• defects of vascular growth into deeper layers at age P9 after tamoxifen administration from age P1-P4
• defects in periphery of superficial retina vascular plexus at age P13 after tamoxifen administration from age P6
• fewer vessels in OPL and minimal vessels in IPL at age P13 after tamoxifen administration from age P6
• increased blood vessel leakage at age P9 after tamoxifen administration from age P1-P4
• slower regression after tamoxifen administration from age P1-P4
• after tamoxifen administration from age P1-P4

mortality/aging
• most mice die by age P9 after tamoxifen administration from age P1-P4
• mice die by age P13-P14 after tamoxifen administration from age P6

nervous system
• extensive blood leakage in brain at age P9 after tamoxifen administration from age P1-P4

growth/size/body
• after tamoxifen administration from age P1-P4
• after tamoxifen administration from age P1-P4

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
exudative vitreoretinopathy DOID:0050535 OMIM:PS133780
J:328283




Genotype
MGI:5299326
cn4
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Twist2tm1(cre)Dor/Twist2+
Genetic
Background
involves: 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Twist2tm1(cre)Dor mutation (0 available); any Twist2 mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• mice exhibit minimal effects on prenatal skeletal development
• at E15, mice exhibit a delay in chondrocyte hypertrophy
• at E18.5, ossification in the skull is slightly delayed




Genotype
MGI:3720633
cn5
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(KRT14-cre)1Efu/?
Genetic
Background
involves: 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Tg(KRT14-cre)1Efu mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• mice have severe intracellular adhesion defects
• in culture, keratinocytes overgrow the monolayer, grow faster than wild-type cells, do not require a feeder layer, are more sensitive to growth factors, and have an increased ability to breakdown matrix

craniofacial

limbs/digits/tail
• limbs fail to develop completely

integument
• in culture, keratinocytes overgrow the monolayer, grow faster than wild-type cells, do not require a feeder layer, are more sensitive to growth factors, and have an increased ability to breakdown matrix
• mice have diminished signs of hair follicle development
• epidermal-dermal boundary was difficult to discern
• clumps of keratinocytes with morphology and differentiation characteristic of epidermis and not hair follicles and that are devoid of surface epidermis are present within the dermis
• large sections of the epidermis are missing
• epidermis is thick and disorganized, particularly within the basal cell layer
• basal cells are round and spinous
• keratinocytes are frequently binucleated and unusually large
• visible peeling occurs
• epidermis is thick and disorganized, particularly within the basal cell layer
• epidermal-dermal boundary was difficult to discern

growth/size/body




Genotype
MGI:3720627
cn6
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(Nes-cre)1Kln/?
Genetic
Background
involves: 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Tg(Nes-cre)1Kln mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die between 2 and 3 weeks after birth

nervous system
• apical-junctional complexes and cell polarity is lost in neuronal progenitor cells
• some cells are non-polarized, round and loosely connected to each other
• at E13.5, neuronal progenitor cells have shorter cell cycles
• however, treatment with cyclopamine rescues normal cell cycling
• mice brains are dysplastic
• ventricular cells are scattered throughout the developing brain forming invasive tumor-like masses that displayed widespread pseudopalisading and the formation of rosettes
• starting at E13.5, embryonic brains are hyperplastic with twice as many cells at birth compared to in wild-type brains
• however, hyperplasia can be reversed by treating embryos with cyclopamine
• brain weight and brain-weight-relative-to-body-weight are increased
• the lateral ventricle is shifted posteriorly and ventrally
• at E13.5, size and thickness of the cortex is increased
• apoptosis in the cortex is reduced by half
• however, treatment with cyclopamine rescues increased apoptosis rates

growth/size/body
• mice are born with enlarged heads
• despite mice having large heads that continue to grow, their bodies exhibit growth retardation

cellular
• at E13.5, neuronal progenitor cells have shorter cell cycles
• however, treatment with cyclopamine rescues normal cell cycling
• apical-junctional complexes and cell polarity is lost in neuronal progenitor cells
• some cells are non-polarized, round and loosely connected to each other
• at E13.5, neuronal progenitor cells have shorter cell cycles
• however, treatment with cyclopamine rescues normal cell cycling




Genotype
MGI:3720651
cn7
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(Wap-cre)11738Mam/?
Genetic
Background
involves: 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Tg(Wap-cre)11738Mam mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• pups with homozygous mothers weight 50% of normal mice
• pups with homozygous mothers fail to thrive

endocrine/exocrine glands
• mammary glands have reduced numbers of epithelial cells
• some epithelial cells remain condensed and disorganized without forming alveolar structures
• lumens are absent from clusters of epithelium
• milk proteins are reduced
• apoptosis in mammary epithelium is increased

integument
• mammary glands have reduced numbers of epithelial cells
• some epithelial cells remain condensed and disorganized without forming alveolar structures
• lumens are absent from clusters of epithelium
• milk proteins are reduced
• apoptosis in mammary epithelium is increased

cellular
• pups with homozygous mothers fail to thrive, are about 50% of normal weight and some do not survive lactation
• in litters that experience lethality, the litters are reduced to 50% at day 5 and 25% by day 10




Genotype
MGI:3720649
cn8
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
Tg(MMTV-cre)4Mam/?
Genetic
Background
involves: 129X1/SvJ * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
Tg(MMTV-cre)4Mam mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mammary glands have reduced numbers of epithelial cells
• some epithelial cells remain condensed and disorganized without forming alveolar structures
• lumens are absent from clusters of epithelium
• milk proteins are reduced
• apoptosis in mammary epithelium is increased
• apoptosis in mammary epithelium is increased

integument
• mammary glands have reduced numbers of epithelial cells
• some epithelial cells remain condensed and disorganized without forming alveolar structures
• lumens are absent from clusters of epithelium
• milk proteins are reduced
• apoptosis in mammary epithelium is increased
• apoptosis in mammary epithelium is increased
• occasionally hair development is not on schedule




Genotype
MGI:5504499
cn9
Allelic
Composition
Ctnna1tm1Efu/Ctnna1tm1Efu
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
Genetic
Background
involves: 129X1/SvJ * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
A1cfTg(Myh6-cre/Esr1*)1Jmk mutation (5 available); any A1cf mutation (39 available)
Ctnna1tm1Efu mutation (1 available); any Ctnna1 mutation (133 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• progressive 8 months after tamoxifen treatment

muscle
• progressive 8 months after tamoxifen treatment





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory